Division of Genetic Medicine and Clinical Pharmacology Archive — Page 9 of 12

Studies by Andrew Glazer, PhD, Giovanni Davogustto, MD, and colleagues found that genetic testing with information from electronic health records can reveal undiagnosed heart rhythm disorders.
April 28, 2022

Studies combine genetic testing, electronic health records to find undiagnosed diseases

Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.

Four medical professionals pose together in front of a wood-paneled wall; the person at left wears a white Vanderbilt University Medical Center lab coat, and the others wear business attire.
April 14, 2022

VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart

A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system.

Red heart-shaped object on blue electrocardiogram grid paper with black heartbeat waveforms.
April 11, 2022

Peptides promote AFib arrhythmia

Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.

Logo reading “All of Us Research Program” in white and light blue on a dark navy background.
March 17, 2022

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.

Glowing cyan electrocardiogram waveform with two prominent heartbeat spikes against a dark blue grid background.
February 24, 2022

VUMC researchers find clue to drug-induced arrhythmias

Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms.

Vanderbilt Center for Tourette Syndrome and Other Tic Disorders team members include, from left, Angela White, RN, Mariana Ciobanu, MD, KellyAnn Primm, OTR/L, David Isaacs, MD, MPH, Heather Riordan, MD, Michelle Eckland, Jessica Stroh, RN, and Kayla Johnson, PharmD.
February 23, 2022

VUMC designated a Tourette syndrome center of excellence

The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence.